Althea Group Holdings Ltd (ASX:AGH) is an Australian-headquartered global pharmaceutical company dedicated to the research, development, manufacturing, and distribution of cannabis-based medicines and related products. Operating across regulated markets in Australia, Europe (UK, Germany), and North America (Canada), Althea aims to improve patient health outcomes through innovative and high-quality medicinal cannabis solutions.
Serves as the central hub for Althea Group's global strategy, corporate governance, financial management, investor relations, and oversight of research, development, and commercial operations worldwide.
Located within 101 Collins Street, a landmark premium-grade office tower in Melbourne's CBD, known for its prestigious address and high-quality amenities.
Professional, innovative, and compliance-focused, reflecting its position in the pharmaceutical and healthcare sector. Emphasizes collaboration, research-driven decision-making, and adherence to stringent regulatory standards.
Key to coordinating Althea's international operations, managing partnerships, and driving the company's growth strategy in the evolving global medicinal cannabis market.
Althea Group supports its global operations through key functions including research and development, licensed manufacturing (notably via its Peak Processing Solutions facility in Canada and contract manufacturers), sales, marketing, and distribution of medicinal cannabis products. The company has established commercial operations and patient access programs in Australia, the United Kingdom, Germany, and Canada, and supplies products to other European markets, leveraging local expertise and regulatory frameworks.
Suite 2, Level 27, 101 Collins Street
Melbourne
VIC
Australia
Address: Peak Processing Solutions, 2655 County Rd 42, Tecumseh, Ontario, N0R 1L0, Canada
Serves as Althea's primary North American manufacturing hub, crucial for product development, quality control, and supply to the Canadian recreational and global medicinal markets.
Address: Althea MMJ UK Ltd, Salisbury House, London Wall, London, EC2M 5PS, United Kingdom
Key entity for accessing and expanding within the growing UK medicinal cannabis market, navigating local regulations, and building brand presence.
Address: Althea Deutschland GmbH, c/o CFO AG, Munscheidstraße 14, 45886 Gelsenkirchen, Germany
Facilitates market entry and growth in Germany, one of Europe's largest and most important medicinal cannabis markets, ensuring compliance and supply chain integrity.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Althea' leadership includes:
Althea has been backed by several prominent investors over the years, including:
Althea Group has strategically bolstered its leadership over the past 12-18 months, appointing a new Chief Financial Officer, a Chief Commercial Officer for Europe, and a new Company Secretary, signaling a focus on financial stewardship, European market expansion, and corporate governance.
Discover the tools Althea uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Althea Group primarily utilizes the email domain '@althea.life' for its corporate communications, including for its executive team. The most commonly observed and verified format is [first_initial].[last_name]. For general inquiries, '@altheagroupholdings.com' is also used.
[first_initial].[last_name]@althea.life
Format
j.fegan@althea.life
Example
85%
Success rate
Proactive Investors • May 21, 2024
Althea Group Holdings Ltd has successfully raised A$2.2 million through a strategic placement and a share purchase plan, aiming to accelerate sales growth and achieve positive cash flow....more
Proactive Investors • May 20, 2024
Althea has appointed Gino Coolegem as its Chief Commercial Officer for Europe to spearhead commercial strategy and expansion in key European medicinal cannabis markets....more
Small Caps • February 28, 2024
Althea Group announced record revenue from its UK operations, driven by a significant increase in patient numbers for its medicinal cannabis products....more
ASX Announcement • November 1, 2023
Althea Group Holdings announced the resignation of Ms Catherine Davies as Company Secretary and the appointment of Mr Michael Fegan as Company Secretary, effective 1 November 2023....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Althea, are just a search away.